Chronic Bronchitis Alternative Therapy

The Lung Institutes Offers an Alternative Therapy for Chronic Bronchitis

If you’re looking for an alternative therapy for chronic bronchitis, cellular therapy may be able to help you achieve the benefits you’re looking for. Many people have been able to better manage their symptoms and improve their quality of life by supplementing their traditional treatments with cellular therapy. This innovative treatment option uses the body’s own cells to reduce inflammation and promote healing.

At the Lung Institute, we offer cellular therapy as an alternative therapy for bronchitis and other lung conditions. In fact, we offer two unique options: venous cellular therapy, in which cells are collected from a patient’s blood, and bone marrow-based cellular therapy, in which cells are collected from a patient’s bone marrow. Both of these natural treatments are:

  • Performed by highly experienced medical professionals
  • Completed on an outpatient basis in our clean and bright facilities
  • Associated with very few side effects (the most common of which is minor, temporary pain where the needle is inserted) and short recovery times (many patients can get back to their day-to-day lives with little to no disruption)

Most of our patients see an improvement within several months of receiving treatment. What’s more, these improvements can be significant. Some individuals are able to reduce their dependence on oxygen therapy and inhalers, while others are able to get back to activities that were once off limits as a result of their severe chronic bronchitis symptoms.

If you’d like to learn more about the potential benefits of using cellular therapy as an alternative therapy for chronic bronchitis, contact the Lung Institute at (800) 729-3065. We can help you determine if cellular therapy is right for you.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.